1 min read|29 words
๐ KEY STAT: GLP-1 medications reduce major cardiovascular events by 20% compared to placebo. The benefits go far beyond weight loss and diabetes control.
Read the full article on GMJ Newsroom โ
Was this article helpful?
Key Finding: GLP-1 Drugs Like Ozempic Cut Heart Attack Risk by 20% in Major Review
Prof. Giorgi Pkhakadze, MD, MPH, PhD, is Editor-in-Chief of the Georgian Medical Journal and Chair of the Public Health Institute of Georgia (PHIG). He is Professor and Head of the Department of Social and Behavioural Sciences at David Tvildiani Medical University, and Secretary/Treasurer of the UEMS Section of Public Health. ORCID: 0000-0001-7609-4515.
